Evolving paradigms for neuroprotection: Molecular identification of ischemic penumbra

Cerebrovascular Diseases

Volumn 21, Issue SUPPL. 2, 2006, Pages 71-79

  Castellanos, Mar ^a   Sobrino, Tomás ^b   Castillo, José ^b  

^a HOSPITAL JOSEP TRUETA   (Spain)

^b Instituto de Salud Carlos III   (Spain)

Author keywords

Energy metabolism; Ischemic stroke; Neuroprotection; Penumbra

Indexed keywords

CYCLOOXYGENASE 2 INHIBITOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEU DIFFERENTIATION FACTOR; PROSTACYCLIN;

BRAIN INFARCTION; BRAIN ISCHEMIA; CELL PROTECTION; ENERGY METABOLISM; HUMAN; NEUROIMAGING; NEUROPROTECTION; PRIORITY JOURNAL; REPERFUSION; REVIEW;

ANIMALS; BRAIN; BRAIN ISCHEMIA; CALCIUM; CEREBROVASCULAR ACCIDENT; DISEASE PROGRESSION; DNA-BINDING PROTEINS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENES, IMMEDIATE-EARLY; GLUTAMIC ACID; HEAT-SHOCK PROTEINS; HUMANS; NEUROPROTECTIVE AGENTS; NUCLEAR RECEPTOR SUBFAMILY 4, GROUP A, MEMBER 1; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, STEROID; STROKE; TRANSCRIPTION FACTORS;

EID: 33646470444     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000091706     Document Type: Review

References (64)

1. Ginsberg MD: Adventures in the pathophysiology of brain ischemia: penumbra, gene expression. Neuroprotection: the 2002 Thomas Willis Lecture. Stroke 2003;34:214-223.
2. Fisher M: Characterizing the target for acute stroke treatment. Stroke 1997;28:866-872.
3. Baron JC, von Kummer R, del Zoppo GJ: Treatment of acute ischemic stroke: challenging the concept of a rigid and universal time window. Stroke 1995;26:2219-2222.
4. NINDS rt-PA Stroke Group: Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581-1587.
5. Hacke W, Kaste M, Fieschi C, von Kummer R, Dávalos A, Deier D, Larrue V, Bluhmki E, Davis S, Donan J, Scheneider D, Díez-Tejedor E, Trovillas P, for the Second European-Australian Acute Stroke Study Investigators: Randomised double-blind, placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischemic stroke (ECASS II). Lancet 1998;352:1245-1251.
6. Silver B, Weber J, Fisher M: Medical therapy for ischemic stroke. Clin Neuropharmacol 1996;19:101-128.
7. Gladstone DJ, Black SE, Hakim AM, for the Heart and Stroke Foundation of Ontario Centre of Excellence in Stroke Recovery: Toward wisdom from failure. Lessons from neuroprotective stroke trials and new therapeutic directions. Stroke 2002;33:2123-2136.
8. Wahlgren NG, Ahmed N: Neuroprotection in cerebral ischaemia: facts and fancies - the need for new approaches. Cerebrovasc Dis 2004;17(suppl 1):153-166.
9. Heiss WD, Sobesky J, Hesselmann V: Identifying thresholds for penumbra and irreversible tissue damage. Stroke 2004;35(suppl I):2671-2674.
10. Kidwell CS, Alger JR, Saver JL: Evolving paradigms in neuroimaging of the ischemic penumbra. Stroke 2004;35(suppl I):2662-2665.
11. Dávalos A, Blanco M, Pedraza S, Leira R, Castellanos M, Pumar JM, Silva Y, Serena J, Castillo J: The clinical-DWI mismatch. A new diagnostic approach to the brain tissue at risk of infarction. Neurology 2004;62:2187-2192.
12. Weinstein PR, Hong S, Sharp FR: Molecular identification of the ischemic penumbra. Stroke 2004;35(suppl I):2666-2670.
13. Sharp FR, Lu A, Tang Y, Millhorn DE: Multiple molecular penumbras after focal cerebral ischemia. J Cereb Blood Flow Metab 2000;20:1011-1032.
14. Kogure T, Kogure K: Molecular and biochemical events within the brain subjected to cerebral ischemia. Clin Neurosci 1997;4:179-183.
15. Samdani AF, Dawson TM, Dawson VI: Nitric oxide synthase in model of focal ischemia. Stroke 197; 28:1283-1288.
16. Hossman KA: Periinfarct depolarizations. Cerebrovasc Brain Metab Rev 1996;8:195-208.
17. Mies G, Iijima T, Hossmann KA: Correlation between periinfarct DC shifts and ischemic neuronal damage in rat. Neuroreport 1993;4:709-711.
18. Mies G, Kohno K, Hossmann KA: Prevention of periinfarct direct current shifts with glutamate antagonist NBQX following occlusion of the middle cerebral artery in the rat. J Cereb Blood Flow Metab 1994;14:802-807.
19. Gill R, Andine P, Hillered L, Persson L, Hagberg H: The effect of MK-801 on cortical spreading depression in the penumbral zone following focal ischemia in the rat. J Cereb Blood Flow Metab 1992;12:371-379.
20. Tatlisumak T, Takano K, Meiler MR, Fisher M: A glycine site antagonist, ZD9379 reduces the number of spreading depressins and infarct size in rats with permanent middle cerebral artery occlusion. Stroke 1998;29:190-195.
21. Castillo J, Davalos A, Naveiro J, Noya M: Neuroexcitatory amino acids and their relation to infarct size and neurological deficit in ischemic stroke. Stroke 1996;27:1060-1065.
22. Castillo J, Dávalos A, Noya M: Progression of ischaemic stroke and excitotoxic amino acids. Lancet 1997;349:79-83.
23. Serena J, Leira R, Castilio J, Pumar JM, Castellanos M, Dávalos A: Neurological deterioration in acute lacunar infarctions. The role of excitotoxicity and inhibitory neurotransmitters. Stroke 2001;32:1154-1161.
24. Castellanos M, Blanco M, Pedraza S, García M, Silva Y, Leira R, Dávalos A: Molecular markers of progressing stroke are associated with diffusion-weighted MRI lesion growth in patients with acute ischemic stroke. Stroke 2004;35:247.
25. Castillo J, Leira R: Predictors of deteriorating cerebral infarct: role of inflammatory mechanisms. Would its early treatment be useful? Cerebrosvasc Dis 2001;11(suppl 1):40-48.
26. Vila N, Castillo J, Dávalos A, Chamorro A: Proinflammatory cytokines and early stroke progression. Stroke 2000;31:2325-2329.
27. Castellanos M, Castillo J, García MM, Leira R, Serena J, Chamorro A, Dávalos A: Inflammation-mediated damage in progressing lacunar infarctions. Stroke 2002;33:982-987.
28. Chen H, Chopp M, Zhang RL, Bodzin G, Chen Q, Rusche JR, Todd RF: Anti-CD11b monoclonal antibody reduces ischemic cell damage after transient focal cerebral ischemia in rat. Ann Neurol 1994;35:458-463.
29. Du C, Hu R, Csernansky CA, Hsu CY, Choi DW: Very delayed infarction after mild focal cerebral ischemia: a role for apoptosis? J Cereb Blood Flow Metab 1996;16:196-201.
30. Nakase T, Söhl G, Theis M, Willecke K, Naus CCG: Increased apoptosis and inflammation after focal brain ischemia in mice lacking connexin-43 in astrocytes. Am J Pathol 2004;164:2067-2075.
31. 1H nuclear magnetic resonance spectroscopy. I. Methodology. J Cereb Blood Flow Metab 1987;7:199-206.
32. 1H magnetic resonance spectroscopy in rats. Neurosurgery 1996;38:121-130.
33. Frykholm P, Hillered L, Langstrom B, Persson L, Valtysson J, Enblad P: Relationship between cerebral blood flow and oxygen metabolism, and extracellular glucose and lactate concentrations during middle cerebral artery occlusion and reperfusion: a microdialysis and positron emission tomography study in nonhuman primates. J Neurosurg 2005;102:1076-1084.
34. Bruhn T, Christensen T, Diener NH: Uptake of glutamate is impaired in the cortical penumbra of the rat following middle cerebral artery occlusion: an in vivo microdialysis extraction study. J Neurosci Res 2003;71:551-558.
35. Bolay H, Gürsoy-Özdemir Y, Sara Y, Onur R, Can A, Dalkara T: Persistent defect in transmitter release an synapsis phosphorylation in cerebral cortex after transient moderate ischemia injury. Stroke 2002;33:1369-1375.
36. A receptors in the cortical penumbra. Brain Res Mol Brain Res 2003;111:24-30.
37. Rebel A, Koehfer RC, Martin LJ: In situ immunoradiographic method for quantification of specific proteins in normal and ischemia brain regions. J Neurosci Methods 2005;143:227-235.
38. Mies G, Ishimaru S, Xie Y, Seo K, Hossmann KA: Ischemic thresholds of cerebral protein synthesis and energy state following middle cerebral artery occlusion in rat. J Cereb Blood Flow Metab 1991;11:753-761.
39. Massa SM, Swanson RA, Shark FR: The stress gene response in brain. Cerebrovasc Brain Metab Rev 1996;8:95-158.
40. Nowak TS Jr, Jacewiwick M: The heat shock/stress response in focal cerebral ischemia. Brain Pathol 1994;4:67-76.
41. Kobayashi S, Welsh FA: Regional alterations of ATP and heat-shock protein-72 mRNA following hypoxia-ischemia in neonatal rat brain. J Cereb Blood Flow Metab 1995;15:1047-1056.
42. Tsuchiya D, Hong S, Matsumori Y, Kayama T, Swanson RA, Dillman WH, Liu J, Panter SS, Weinstein PR: Overexpression of rat heat shock protein 70 reduces neuronal injury after transient focal ischemia, transient global ischemia, or kainic acid-induced seizures. Neurosurgery 2003;53:1179-1188.
43. States BA, Honkaniemi J, Weinstein PR, Sharp FR: DNA fragmentation and HSP70 protein induction in hippocampus and cortex occurs in separate neurons following permanent middle cerebral artery occlusions. J Cereb Blood Flow Metab 1996;16:1165-1175.
44. Plumier JC, Armstrong JN, Wood NI, Babity JM, Hamilton TC, Hunter AJ, Robertson HA, Currie RW: Differential expression of c-fos, Hsp70 and Hsp27 after protothrombotic injury in the rat brain. Brain Res Mol Brain Res 1997;45:239-246.
45. Piao CS, Kim SW, Kim JB, Lee JK: Co-induction of αB-crystallin and MAPKAPK-2 in astrocytes in the penumbra after transient focal cerebral ischemia. Exp Brain Res 2005;163:421-429.
46. Nimura T, Weinstein PR, Massa SM, Panter S, Sharp FR: Heme oxygenase-1 (HO-1) protein induction in rat brain following focal ischemia. Brain Res Mol Brain Res 1996;37:201-208.
47. Hata R, Mies G, Wiessner C, Hossmann KA: Differential expression of c-fos and hsp72 mRNA in focal cerebral ischemia of mice. Neuroreport 1998;9:27-32.
48. Hata R, Maeda K, Herman D, Mies G, Hossmann KA: Evolution of brain infarction after transient focal cerebral ischemia in mice. J Cereb Blood Flow Metab 2000;20:937-946.
49. Xu Z, Jiang J, Ford G, Ford BD: Neuregulin-1 is neuroprotective and attenuates inflammatory responses induced by ischemic stroke. Biochem Biophys Res Commun 2004;322:440-446.
50. Koistinaho J, Pasonen S, Yrjanheikki J, Chan PH: Spreading depression-induced gene expression is regulated by plasma glucose. Stroke 1999;30:114-119.
51. Sairanen T, Ristimaki A, Karjalinen-Lindsberg ML, Paetau A, Kaste M, Lindsberg PJ: Cyclooxygenase-2 is induced globally in infarcted human brain. Ann Neurol 1998;43:738-747.
52. Nagayama M, Niwa K, Nagayama T, Ross ME, Iadecola C: The cyclooxygenase-2 inhibitor NS-398 ameliorates ischemic brain injury in wild-type mice but not in mice with deletion of the inducible nitric oxide synthase gene. J Cereb Blood Flow Metab 1999;19:1213-1219.
53. + concentration reduces the efficacy of N-methyl-D-aspartate receptor antagonists to block spreading depression-like depolarizations and spreading ischemia. Stroke 2005;36:1270-1277.
54. Castillo J, Moro MA, Blanco M, Leira R, Serena J, Lizasoain I, Dávalos A: The release of tumor necrosis factor-α is associated with ischemic tolerance in human stroke. Ann Neurol 2003;54:811-819.
55. Pradillo JM, Romera C, Hurtado O, Cárdenas A, Moro MA, Leza JC, Dávalos A, Castillo J, Lorenso P, Lizasoain I: TNFR1 upregulation mediates tolerance after brain ischemic pre-conditioning. J Cereb Blood Flow Metab 2005;25:193-203.
56. Bunn HF, Poyton RO: Oxygen sensing and molecular adaptation to hypoxia. Physiol Rev 1996;76:839-885.
57. Bergeron M, Yu AY, Solway KE, Semenza GL, Sharp FR: Induction of hypoxia-inducible factor-1 and its target genes following focal ischemia in rat brain. Eur J Neurosci 1999;11:4159-4170.
58. Hill WD, Hess DC, Martin-Studdard A, Carothers JJ, Zheng J, Hale D, Maeda M, Fagan SC, Carroll JE, Conway SJ: SDF-1 (CXCL12) is upregulated in the ischemic penumbra following stroke: association with bone marrow cell homing to injury. J Neuropathol Exp Neurol 2004;63:84-96.
59. 2 synthase expression after cerebral ischemia-reperfusion. J Cereb Blood Flow Metab 2005. Adv online publ, Aug 10, 2005.
60. Schmidt-Kastner R, Zhang B, Belayev L, Khoutorova L, Amin R, Busto R, Ginsberg MD: DNA microarray analysis of cortical gene expression during early recirculation after focal brain ischemia in rat. Brain Res Mol Brain 2002;108:81-93.
61. An G, Lin TN, Liu JS, Xue JJ, He YY, Hsu CY: Expression of c-fos and c-jun family genes after focal cerebral ischemia. Ann Neurol 1993;33:457-464.
62. Collaco-Moraes Y, Aspey BS, de Belleroche JS, Harrison MJ: Focal ischemia causes an extensive induction of immediate early genes that are sensitive to MK-801. Stroke 1994;25:1855-1861.
63. Herrera DG, Robertson HA: Application of potassium chloride to the brain surface induces the c-fos proto-oncogene: reversal by MK-801. Brain Res 1990;510:166-170.
64. Chen J, Graham SH, Chan PH, Lan J, Zhou RL, Simon RP: Bcl-2 is expressed in neurons that survive focal ischemia in the rat. Neuroreport 1995;6:394-398.